
12.15 BATS BZX Real-Time Price As of 3:05pm ET | ![]() Today’s Change | 11.10 Today|||52-Week Range 37.98 | -34.18% Year-to-Date |
The 12 analysts offering 12-month price forecasts for Revance Therapeutics Inc have a median target of 35.00, with a high estimate of 65.00 and a low estimate of 15.00. The median estimate represents a +188.07% increase from the last price of 12.15.
The current consensus among 12 polled investment analysts is to Buy stock in Revance Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.